The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Dobutamine 12.5mg/ml Concentrate for solution for infusion

12.5 milligram(s)/millilitre Concentrate for solution for infusion

Baxter Holding B.V.PA2299/039/001

Main Information

Trade NameDobutamine 12.5mg/ml Concentrate for solution for infusion
Active SubstancesDobutamine
Strength12.5 milligram(s)/millilitre
Dosage FormConcentrate for solution for infusion
Licence HolderBaxter Holding B.V.
Licence NumberPA2299/039/001

Group Information

ATC CodeC01CA Adrenergic and dopaminergic agents
C01CA07 dobutamine

Status

Authorised/WithdrawnAuthorised
Licence Issued22/07/2011
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back